| Patents for A61P 27 - Drugs for disorders of the senses (53,017) |
|---|
| 06/24/2004 | WO2003053966A8 1-alkyl-1-azoniabicyclo [2.2.2] octane carbamate derivatives and their use as muscarinic receptor antagonists |
| 06/24/2004 | WO2003051841A3 Compounds and uses thereof for decreasing activity of hormone-sensitive lipase |
| 06/24/2004 | WO2003018044A8 New drug |
| 06/24/2004 | US20040122254 Selective cyclooxygenase-2(COX-2) inhibitors; free of gastrointestinal side effects; treating eye disorders such as glaucoma or selective cyclooxygenase-2(COX-2) inhibitors, rheumatoid arthritis, arthritis, pain, inflammation |
| 06/24/2004 | US20040122102 compounds are potent ocular hypotensives, and are suitable for the management of glaucoma; they also are smooth muscle relaxants with broad application in systemic hypertensive and pulmonary diseases, gastrointestinal, reproduction disorders etc |
| 06/24/2004 | US20040122083 Antitubulin assembly and cell growth inhibitor denominated "dioxostatin" |
| 06/24/2004 | US20040122040 Bicyclic guanidine derivatives and therapeutic uses thereof |
| 06/24/2004 | US20040122035 selective inhibitors of cyclic guanosine monophosphate (cGMP)-specific phosphodiesterase-5 (PDE5); sexual disorders, cardiovascular disorders; 1-(2H-benzo[d]1,3-dioxolan-5-yl)(1,2,3,4-tetrahydro- beta -carbolin-2-yl)-2-naphthyl ketone for example |
| 06/24/2004 | US20040122034 Polymorph forms of n-(2,3-dimethyl-5,6,7,8-tetrahydrofuro[2,3-b]quinolin-4-yl)-2-(2-oxopyrrolidin-1-1yl)acetamide |
| 06/24/2004 | US20040122030 Substituted phthalimide and isoquinoline derivatives; thalidomide analogs that lack the piperidine-2,6-dione moiety of thalidomide |
| 06/24/2004 | US20040122004 such as (1R,2R)-N-[(1S)-2-amino-1-(4-fluorophenyl)-2-oxoethyl]-2-(4-{[{[ethyl(2-hydroxyethyl)amino]carbonyl}(4-fluorophenyl)amino]methyl}phenyl)cyclohexanecarboxamide; for prevention/treatment of cardiovascular disorders |
| 06/24/2004 | US20040121962 Prodrugs of excitatory amino acids |
| 06/24/2004 | US20040120967 Use of L-carnitine for the treatment of cataract of non diabetic origin due to altered chaperone proteins by stabilizing the protein activity |
| 06/23/2004 | EP1431275A1 Diaryl ether derivative, addition salt thereof, and immunosuppressant |
| 06/23/2004 | EP1430894A1 Lymphocytic activation inhibitor and remedial agent for autoimmune disease |
| 06/23/2004 | EP1430126A1 Dna sequences for human angiogenesis genes |
| 06/23/2004 | EP1430120A1 Inhibitors of glycogen synthase kinase-3 (gsk-3) for treating glaucoma |
| 06/23/2004 | EP1430057A2 Substituted 2-pyridinyl-6,7,8,9-tetrahydropyrimido 1,2-a]pyrimidin-4-one and 7-pyridinyl-2,3-dihydroimidazo 1,2-a]pyrimidin-5(1h)one derivatives |
| 06/23/2004 | EP1430056A1 Substituted 2-pyrimidinyl-6,7,8,9-tetrahydropyrimido 1,2-a]pyrimidin-4-one and 7-pyrimidinyl-2,3-dihydroimidazo 1,2-a]pyrimidin-5(1h)one derivatives for neurodegenerative disorders |
| 06/23/2004 | EP1430043A1 Benzofuran and dihydrobenzofuran derivatives useful as beta-3 adrenoreceptor agonists |
| 06/23/2004 | EP1430042A2 Bicyclic heterocycles as rxr ligands |
| 06/23/2004 | EP1429800A2 Vaccine and method for treatment of motor neurone diseases |
| 06/23/2004 | EP1429799A2 Kgf polypeptide compositions |
| 06/23/2004 | EP1429796A2 Peptide antiangiogenic drugs |
| 06/23/2004 | EP1429780A1 Method of treating middle ear infections |
| 06/23/2004 | EP1429777A1 Ophthalmologic treatment methods using selective inos inhibitors |
| 06/23/2004 | EP1429773A1 Process for making substituted pyrazoles |
| 06/23/2004 | EP1429762A1 4,5-dihydro-1h-pyrazole derivatives having potent cb1-antagonistic activity |
| 06/23/2004 | EP1429761A1 Novel 4,5-dihydro-1h-pyrazole derivatives having cb1-antagonistic activity |
| 06/23/2004 | EP1429725A1 Ophthalmic depot formulations for periocular or subconjunctival administration |
| 06/23/2004 | EP1429617A2 Methods for sterilizing preparations of digestive enzymes |
| 06/23/2004 | EP1429602A1 Methods for treating disorders using plant extracts |
| 06/23/2004 | EP1353906B1 Process for the preparation of (3-cyano-1h-indol-7-yl)(4-(4-fluorophenethyl)piperazin-1-yl)-methanone and salts thereof |
| 06/23/2004 | EP1252157B1 Pyrimidine carboxamides useful as inhibitors of pde4 isozymes |
| 06/23/2004 | EP1171573B1 Arpe-19 as a platform cell line for encapsulated cell-based delivery |
| 06/23/2004 | EP1066283B1 Substituted indolealkanoic acids |
| 06/23/2004 | CN1507451A Cyclosporin-pro-drug and use thereof as a medicament |
| 06/23/2004 | CN1507447A Substituted pyrazolopyrimidines and thiazolopyrimidines used as analgesics |
| 06/23/2004 | CN1507444A 2,3-diazanaphthalene derivatives with angiogenesis inhibiting activity |
| 06/23/2004 | CN1507437A Aralkylpiperazines with serotonin 5-HTIA activity |
| 06/23/2004 | CN1506085A Chinese goldthread soft capsule for clearing away adverse lung energy and its prepn process |
| 06/23/2004 | CN1506080A Medicine for treating turbid vitrious body and its prepn |
| 06/23/2004 | CN1506056A Cell growth regulating factor R and its prepn process |
| 06/23/2004 | CN1154646C Benzisozazoles and phenones as alpha antagonist |
| 06/23/2004 | CN1154490C Celecoxib compositions |
| 06/23/2004 | CN1154489C Heterocyclic vinylethers against neurological disorders |
| 06/22/2004 | US6753332 Sulfonyl heteroaryl triazoles as anti-inflammatory/analgesic agents |
| 06/22/2004 | US6753327 Neurodegenerative disorder or neuronal damage treatment; inhibitors of calpain or cathepsin cysteine proteases; antiischemic agents; reperfusion injuries |
| 06/17/2004 | WO2004050116A1 Protease inhibitor |
| 06/17/2004 | WO2004050114A1 Novel agent for improving neurotransmission failure |
| 06/17/2004 | WO2004050086A1 Derivatives of indole-3-carboxamide, preparation method thereof and application of same in therapeutics |
| 06/17/2004 | WO2004050075A1 Use of 2,5-dihydroxybenzenesulfonic compounds for the treatment of disorders based on an impairment of no production and/or of regulation of edhf function |
| 06/17/2004 | WO2004050074A1 Use of 2,5-dihydroxybenzenesulfonic compounds for the treatment of disorders based on an impairment of no production and/or of regulation of edhf function |
| 06/17/2004 | WO2004050060A1 Drug delivery system using subconjunctival depot |
| 06/17/2004 | WO2004032911A3 Styrylacrylonitrile compounds for inhibition of vascular endothelial growth factor |
| 06/17/2004 | WO2004012651A3 Composition for heart disease, method to prepare same and uses thereof |
| 06/17/2004 | WO2004003164A3 Methods of organ regeneration |
| 06/17/2004 | WO2003106660A3 Immunomodulation and effect on cell processes relating to serotonin family receptors and the blood-brain barrier |
| 06/17/2004 | WO2003105781A3 Ophthalmic compositions for treating ocular hypertension |
| 06/17/2004 | WO2003070184A3 Sodium channel blockers |
| 06/17/2004 | US20040116706 Therapeutic ureas |
| 06/17/2004 | US20040116703 Central nervous system disorders, nicotinic acetylcholine receptors; endocrine diseases; antiinflammatory agents; analgesics; drug dependency; skin disorders; Alzheimer's and Parkinson's disease |
| 06/17/2004 | US20040116697 Novel compounds |
| 06/17/2004 | US20040116535 enantiomers or racemic mixtures of mexiletine, used for prophylaxis of tinnitus |
| 06/17/2004 | US20040116507 2-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses |
| 06/17/2004 | US20040116495 Compounds and methods |
| 06/17/2004 | US20040116486 Metalloproteinase inhibitors |
| 06/17/2004 | US20040116472 inhibit angiogenesis, tumor metastasis and growth, osteoporosis, Paget's disease, hypercalcemia of malignancy, retinopathy, macular degeneration, arthritis, periodontal disease, smooth muscle cell migration and viral diseases |
| 06/17/2004 | US20040116471 Indolylpiperidine derivatives as antihistaminic aand antiallergic agents |
| 06/17/2004 | US20040116458 Chemical compounds |
| 06/17/2004 | US20040116439 Serine protease inhibitors |
| 06/17/2004 | US20040116431 Substituted aryl compounds as novel cyclooxygenase-2 selective inhibitors, compositions and methods of use |
| 06/17/2004 | US20040116426 Small molecules useful in the treatment of inflammatory disease |
| 06/17/2004 | US20040116423 5-Aryltetrazole compounds, compositions thereof, and uses therefor |
| 06/17/2004 | US20040116355 Caspase inhibitors and the use thereof |
| 06/17/2004 | US20040116353 Derivatives of n-(arylsulfonyl)beta-aminoacids comprising a substituted aminomethyl group, the preparation method thereof and the pharmaceutical compositions containing same |
| 06/17/2004 | US20040116342 Therapeutic use of a SMR1-peptide or a pharmaceutically active amount of SMR1-peptide, for the preparation of a therapeutic formulation for preventing or treating diseases wherein a modulation of activity of a membrane metallopeptidase is sought |
| 06/17/2004 | US20040115761 Polypeptides and nucleic acids encoding same |
| 06/17/2004 | US20040115181 Composition for transmucosal adminstration containing conenzyme q as the active ingredient |
| 06/17/2004 | CA2507750A1 Use of 2,5-dihydroxybenzenesulfonic compounds for the treatment of disorders based on an impairment of no production and/or of regulation of edhf function |
| 06/17/2004 | CA2485957A1 Protease inhibitor |
| 06/16/2004 | EP1428538A1 Ectocornea extension promoters |
| 06/16/2004 | EP1427857A2 Mid 4460, a human tyrosine phosphatase family member and uses therefor |
| 06/16/2004 | EP1427841A2 Nucleic acid-associated proteins |
| 06/16/2004 | EP1427720A1 3-substituted-4-pyrimidone derivatives |
| 06/16/2004 | EP1427709A1 3-substituted-4-pyrimidone derivatives |
| 06/16/2004 | EP1427436A2 Use of milk serum apoproteins in the prophylaxis or treatment of microbial or viral infection |
| 06/16/2004 | EP1427427A1 Derivatives of partially desulphated glycosaminoglycans as heparanase inhibitors, endowed with antiangiogenic activity and devoid of anticoagulating effect |
| 06/16/2004 | EP1351958B1 Imidazolo-5-yl-2-anilino-pyrimidines as agents for the inhibition of the cell proliferation |
| 06/16/2004 | EP1315731B1 2-pyridinyl-6,7,8,9-tetrahydropyrimido[1,2-a]pyrimidin-4-one and 7-pyridinyl-2,3-dihydroimidazo[1,2-a]pyrimidin-5(1h)one derivatives |
| 06/16/2004 | EP1255751B1 1,3-dihydro-2h-indol-2-one derivatives and their use as ligands for v1b or v1b and v1a arginine-vasopressin receptors |
| 06/16/2004 | EP1244643B1 Tryptase inhibitors |
| 06/16/2004 | EP1235777B1 Vitamin d analogues |
| 06/16/2004 | EP1200096B1 Tixocortol pivalate suspension, mouth-wash based thereon and packaging containing same |
| 06/16/2004 | EP1119570B1 Tricyclic delta3-piperidines as pharmaceuticals |
| 06/16/2004 | EP1117408B1 Use of diltiazem for treating retinal pathologies |
| 06/16/2004 | EP1098649B1 Method for stabilizing pharmaceutical compositions by special use of an antioxidant |
| 06/16/2004 | CN1505640A T cell receptor Vbeta-Dbeta-Jbeta sequence and methods for its detection |
| 06/16/2004 | CN1505638A Protection and enhancement of erythropoietin-responsive cells, tissues and organs |
| 06/16/2004 | CN1505627A Cyclic amp-specific phosphodiesterase inhibitors |